Leading small business
innovation and commercialization
in the fight against cancer
The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.
Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.
Their MxStructure™ software uses auto-segmentation to better focus radiation treatment and minimize exposure to surrounding healthy tissue. They were acquired by Accuray in 2012.
AntiCancer, the San Diego-based biotechnology company, was awarded Phase I and II SBIR grants and contracts that have led to the commercialization of three cancer research tools: MetaMouse®, AngioMouse®, and OncoBrite®.
Awarded more than $4 million to develop a technology platform of safe and effective carriers for therapeutic vaccines based on hemocyanin from the keyhole limpet (KLH) protein.
The NCI SBIR team will be at the AACR 2016! Find us at kiosk #1012.
Did you miss our last webinar?
Investor Initiatives for NCI SBIR companies
Application Due : Feb 10, 2016
NCI SBIR/STTR Companies! Do you want to put your technology in front of investors? Do you want to get connected to potential partners? If so, Apply Now.
The purpose of this Notice is to clarify the types of applications which can be submitted to the National Institutes of Health Small Business
The NIH is holding an I-Corps Office Hour Q&A session with an I-Corps instructor on February 10. Sign up now and get your I-Corps questions answered!